Bio Medica Laboratories Financials

NSE: BMLL

₹177.00

₹14.70 (9.06%)

As on 04-Sep-2026 15:50IST

Market cap

₹223 Cr

Revenue (TTM)

₹38 Cr

P/E Ratio

18.6

P/B Ratio

--

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	38.20	15.25	16.23	--	--	--
Total Income	38.33	15.34	16.25	--	--	--
Total Expenditure	22.82	9.62	14.53	--	--	--
EBITDA	15.37	5.63	1.70	--	--	--
Depreciation	1.01	1.11	0.50	--	--	--
EBIT	14.37	4.52	1.20	--	--	--
Interest	1.35	0.97	0.77	--	--	--
Other Income	0.13	0.09	0.02	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	13.14	3.65	0.45	--	--	--
Provision for Tax	3.35	1.15	0.12	--	--	--
Profit after Tax	9.79	2.50	0.33	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	14.73	4.94	2.44	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.17	7.91	4.91	--	--	--
Current Liabilities	16.99	6.56	10.19	--	--	--
Total Liabilities	39.12	19.53	17.57	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	7.81	8.85	8.44	--	--	--
Current Assets	31.09	10.55	9.10	--	--	--
Total Assets	39.12	19.53	17.57	--	--	--
Total Debt*	15.01	10.49	9.61	--	--	--
Net Current Assets	14.10	4.00	-1.09	--	--	--
Contingent Liabilities	0.05	0.05	0.05	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-3.67	1.62	2.29	--	--	--
Cash Flow from Investing Activities	0.34	-1.54	-1.69	--	--	--
Cash from Financing Activities	3.33	-0.08	-2.13	--	--	--
Net Cash Inflow / Outflow	0.00	0.00	-1.52	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	10.67	2.72	0.36	--	--	--
Cash EPS (₹)	11.77	3.93	0.90	--	--	--
Adjusted Book Value (₹)	16.05	5.38	2.66	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-4.00	162.41	229.31	--	--	--
Free Cash Flow per Share (₹)	-7.59	-188.79	17.27	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	64.18	33.61	10.17	--	--	--
ROE (%)	99.59	67.74	13.67	--	--	--
ROA (%)	33.60	13.53	1.90	--	--	--
EBIT Margin (%)	37.62	29.65	7.41	--	--	--
Net Margin (%)	25.56	16.28	2.05	--	--	--
Cash Profit Margin (%)	28.28	23.66	5.12	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	150.47	-6.03	--	--	--	--
EBIT Growth (%)	217.76	275.79	--	--	--	--
Net Profit Growth (%)	292.00	649.24	--	--	--	--
EPS Growth (%)	292.00	649.22	--	--	--	--
Book Value Growth (%)	198.35	102.42	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.56	1.85	5.64	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	1.02	2.12	3.94	--	--	--
Short term debt to equity ratio	0.43	0.35	1.53	--	--	--
Current Ratio	1.83	1.61	0.89	--	--	--
Quick Ratio	0.76	0.49	0.51	--	--	--
Interest Coverage	10.70	4.78	1.59	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	10.73	15.32	25.10	--	--	--
Asset Turnover	1.31	0.83	0.93	--	--	--
Receivable days	30.75	76.70	91.61	--	--	--
Inventory Days	121.86	134.86	87.76	--	--	--
Payable days	117.74	361.42	360.74	--	--	--
Cash Conversion Cycle	34.88	-149.86	-181.37	--	--	--